GuglielmoBJHohnDCKooPJ, Antibiotic prophylaxis in surgical procedures. A critical analysis of the literature. Arch Surg1983; 118: 943–55.
2.
DipiroJTRecordKESchanzenbachKS, Antimicrobial prophylaxis in surgery. Part 2. Am J Hosp Pharm1981; 38: 487–94.
3.
SanfelippoPMDanielsonGK. Complications associated with median sternotomy. J Thorac Cardiovasc Surg1972; 63: 419–23.
4.
SlamaTGSklarSJMisinskiJFessSW. Randomized comparison of cefamandole, cefazolin, and cefuroxime prophylaxis in open heart surgery. Antimicrob Agents Chemother1986; 29: 744–7.
5.
KaiserABPetracekMRLeaJW, Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Ann Surg1987; 206: 791–7.
ParrGVSAberRC. Comparative efficacy and tolerance of cefamandole and cephalothin as prophylaxis for open heart surgery. J Cardiovasc Surg1982; 23: 305–8.
8.
HillisDJRosenfeldtFISpicerWJStirlingGR. Antibiotic prophylaxis for coronary bypass grafting. Comparison of a five-day and a two-day course. J Thorac Cardiovasc Surg1983; 86: 217–21.
9.
PetersonCDLakeKDAromKVLoveKR. Antibiotic prophylaxis in open-heart surgery patients: Comparison of cefamandole and cefuroxime. Drug Intell Clin Pharm1987; 21: 728–32.
10.
WilsonAPRTreasureTGrunebergRNSturridgeMFRossDN. Antibiotic prophylaxis in cardiac surgery: A prospective comparison of two dosage regimens of teicoplanin with a combination of flucloxacillin and tobramycin. J Antimicrob Chemother1988; 21: 213–23.
SabathLD. Reappraisal of the antistaphylococcal activities of first-generation (narrow-spectrum) and second-generation (expanded-spectrum) cephalosporins. Antimicrob Agents Chemother1989; 33: 407–11.
13.
NafzingerDAWenzelRP. Coagulase-negative staphylococci: Epidemiology, evaluation, and therapy. Infect Dis Clin North Am1989; 3: 915–29.
14.
Infection control report. Winnipeg, Manitoba, Canada: Health Science Centre, 1989.
15.
KropecADaschnerF. In-vitro activity of fleroxacin and fourteen other antimicrobials against slime and non-slime producing Staphylococcus epidermidis. Chemotherapy1989; 35: 351–4.
16.
ChandrasekarPHSluchakJA. Newer agents against methicillin and/or gentamicin-resistant and susceptible-staphylococci. Chemotherapy1989; 35: 333–7.
17.
Antimicrobial susceptibility report. Winnipeg, Manitoba, Canada: Health Science Centre, 1989.
18.
SmithJAHenryDABourgaultAM, Comparison of agar disk diffusion, microdilution for testing antimicrobial susceptibility of coagulase negative staphylococci. J Clin Microbiol1987; 25: 1741–6.
19.
BrumfittWHamilton-MillerJ. Methicillin-resistant Staphylococcus aureus. N Engl J Med1989; 320: 1188–96.
20.
KernodleDSClassenDCBurkeJP, Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections. JAMA1990; 263: 961–6.
21.
ZhanelGGHobenDJHardingGKM. Subinhibitory antimicrobial concentrations: Effects on bacteria and clinical significance. Can J Infect Dis1991 (in press).
22.
SteinPDHarkenDEDexterL. The nature and prevention of prosthetic valve endocarditis. Am Heart J1966; 71: 393–407.
23.
ShaferRBHallWH. Bacterial endocarditis following open heart surgery. Am J Cardiol1970; 25: 602–7.
24.
FongIWBakerCBMcKeeDC. The value of prophylactic antibiotics in aorta-coronary bypass operations. J Thorac Cardiovasc Surg1979; 78: 908–13.
25.
PlattRMunozAStellaJ., Antibiotic prophylaxis for cardiovascular surgery. Efficacy with coronary artery bypass. Ann Intern Med1984; 101: 770–4.
26.
BeamTRRabbTASpoonerJA, Comparison of ceftriaxone and cefazolin prophylaxis against infection in open heart surgery. Am J Surg1984; 148 (suppl 4A): 8–14.
27.
MeszarosRWindischMKoltaiCLukacsL. Comparative study of cefamandole versus cephalothin as antibiotic prophylaxis for open heart surgery. Cor Vasa1986; 28: 61–6.
28.
JoyceFSSzczepanskiKP. A double-blind comparative study of prophylactic antibiotic therapy in open heart surgery: Penicillin-G versus vancomycin. Thorac Cardiovasc Surg1986; 34: 100–3.
29.
GentryLOZeluffBJCooleyDA. Antibiotic prophylaxis in open heart surgery: A comparison of cefamandole, cefuroxime, and cefazolin. Ann Thorac Surg1988; 46: 167–71.
30.
ConklinCMGrayRJNeilsonD., Determinants of wound infection incidence after isolated coronary artery bypass surgery in patients randomized to receive prophylactic cefuroxime or cefazolin. Ann Thorac Surg1988; 46: 172–7.
31.
ThurerRJBognoloDVargasA., The management of mediastinal infection following cardiac surgery. J Thorac Cardiovasc Surg1974; 68: 962–8.
32.
SackettDL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest1989; 95 (suppl): 2–4S.
33.
EinarsonTRMcGhanWFBootmanJL, Meta-analysis: Quantitative integration of independent research results. Am J Hosp Pharm1985; 42: 1957–64.
34.
GoodmanJSSchaffnerWCollinsHA, Infection after cardiovascular surgery: Clinical study including examination of antimicrobial prophylaxis. N Engl J Med1968; 278: 117–23.
35.
AustinTWColesJCBurnettRGoldbachM. Aortocoronary bypass procedures and sternotomy infections: A study of antistaphylococcal prophylaxis. Can J Surg1980; 23: 483–5.
36.
FeketyFRCluffLESabistonDC, A study of antibiotic prophylaxis in cardiac surgery. J Thorac Cardiovasc Surg1969; 57: 757–63.
37.
AbramowiczM, ed. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther1989; 31: 105–8.
38.
BeamT. Perioperative prevention of infection in cardiac surgery. Antibiot Chemother1985; 33: 114–39.
39.
ConteJECohenSNRoeBBElashoffRM. Antibiotic prophylaxis and cardiac surgery. Ann Intern Med1972; 76: 943–9.
40.
ZhanelGGGinASPrzybyloALouieTJOttenN. Effect of interventions on prescribing of antimicrobials for prophylaxis in obstetric and gynecologic surgery. Am J Hosp Pharm1989; 46: 2493–6.
41.
BourkeGJDalyLEMcGilvrayJ. Interpretation and uses of medical statistics. 3rd ed. Oxford: Blackwell Scientific Publications, 1985: 312–4.
42.
RoachACKernodleDSKaiserAB. Selecting cost-effective antimicrobial prophylaxis in surgery: Are we getting what we pay for?DICP Ann Pharmacother1990; 24: 183–5.
